It has been reported that the binding of GRK2 to D1 receptors leads to the phosphorylation of D1 receptors.18 Given that this patient is particularly sensitive to the efficacy of D1 receptor agonists, we aim to evaluate the effectiveness of a D1R agonist SFK81297 in the treatment of movement disorders. This evidence concerns the gene GRK2 and movement disorder.